This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Corneal Disorders  • Dry Eye Syndromes  • Drug Therapy  • Drug Therapy, Other  • Endocrine Diseases  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

Ian S. Zagon, MS, PhD; Matthew S. Klocek, MS, PhD; Joseph W. Sassani, MD, MHA; Patricia J. McLaughlin, MS, DEd

Arch Ophthalmol. 2009;127(11):1468-1473.

Objective  To determine if topical application of naltrexone hydrochloride (NTX), an opioid antagonist, restores tear production and corneal sensation in rats with diabetes mellitus.

Methods  Type 1 diabetes was induced with streptozotocin in rats. Tear production was measured by the Schirmer test, and corneal sensitivity, by an esthesiometer. Eye drops of 10^–5M NTX or sterile vehicle were administered either once only or 4 times a day for 1 or 5 days; a single drop of insulin (1 U) was given once only.

Results  Dry eye and corneal insensitivity were detected in the diabetic rats beginning 5 weeks after streptozotocin injection. One drop of NTX or 4 times a day for 1 or 5 days reestablished tear production and corneal sensitivity within 1 hour of administration. The reversal of dry eye lasted for up to 2 to 3 days depending on drug regimen, but restitution of corneal sensation lasted for 4 to 7 days. Topical application of 1 eye drop of insulin restored corneal sensitivity within 1 hour and lasted for at least 2 days. In contrast, 1 eye drop of insulin did not increase tear production at 1, 24, or 48 hours compared with diabetic animals receiving sterile vehicle.

Conclusion  Topical treatment with NTX normalizes tear production and corneal sensitivity in type 1 diabetic rats.

Clinical Relevance  Topical application of NTX to the ocular surface may serve as an important strategy for treating dry eye and corneal anesthesia in diabetes. Its effect, if any, in other forms of decreased corneal sensitivity and/or dry eye should be investigated.

Author Affiliations: Departments of Neural and Behavioral Sciences (Drs Zagon, Klocek, and McLaughlin) and Ophthalmology (Dr Sassani), The Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?